9 Meters Biopharma, Inc. (NMTRQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
+0.0001 (9,900.00%)
Feb 19, 2025, 10:57 AM EST
9 Meters Biopharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2016 |
| Net Income | -46.28 | -43.77 | -36.78 | -61.5 | -27.05 | -24.16 | Upgrade
|
| Depreciation & Amortization | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | Upgrade
|
| Other Amortization | 2.41 | 1.83 | 0.04 | 3.72 | 1.17 | 5.59 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | 0.04 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 2.61 | 28.75 | - | - | Upgrade
|
| Stock-Based Compensation | 3.99 | 3.94 | 2.41 | 4.72 | 2.87 | 3.81 | Upgrade
|
| Other Operating Activities | 0.58 | 0.08 | -0.01 | 4.06 | 1.13 | 0.23 | Upgrade
|
| Change in Accounts Payable | 2.32 | 2.62 | 1.05 | -2.47 | 0.12 | 0.09 | Upgrade
|
| Change in Other Net Operating Assets | -0.26 | -1.96 | 1.18 | 3.24 | 3.77 | -0.74 | Upgrade
|
| Operating Cash Flow | -37.24 | -37.24 | -29.48 | -19.41 | -17.97 | -15.17 | Upgrade
|
| Capital Expenditures | - | -0 | -0.01 | -0 | -0.01 | -0.01 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -2.49 | -3.18 | - | - | Upgrade
|
| Other Investing Activities | - | - | 0.08 | - | - | - | Upgrade
|
| Investing Cash Flow | - | -0 | -2.43 | -3.19 | -0.01 | -0.01 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 2.5 | 5 | 3.35 | Upgrade
|
| Long-Term Debt Issued | - | 21 | - | - | - | - | Upgrade
|
| Total Debt Issued | 21 | 21 | - | 2.5 | 5 | 3.35 | Upgrade
|
| Short-Term Debt Repaid | - | - | -0.06 | -2.46 | -7.79 | -0.28 | Upgrade
|
| Total Debt Repaid | -16.75 | - | -0.06 | -2.46 | -7.79 | -0.28 | Upgrade
|
| Net Debt Issued (Repaid) | 4.25 | 21 | -0.06 | 0.04 | -2.79 | 3.07 | Upgrade
|
| Issuance of Common Stock | 5 | - | 44.01 | 39.68 | 20.74 | 19.24 | Upgrade
|
| Other Financing Activities | -1.63 | -1.09 | -2.9 | -6.42 | -1.1 | -1.76 | Upgrade
|
| Financing Cash Flow | 7.63 | 19.91 | 41.05 | 55.86 | 16.84 | 20.56 | Upgrade
|
| Net Cash Flow | -29.62 | -17.33 | 9.14 | 33.26 | -1.14 | 5.37 | Upgrade
|
| Free Cash Flow | -37.24 | -37.25 | -29.49 | -19.41 | -17.98 | -15.18 | Upgrade
|
| Free Cash Flow Per Share | -2.84 | -2.87 | -2.43 | -3.68 | -10.79 | -12.26 | Upgrade
|
| Cash Interest Paid | 1.01 | 0.84 | 0 | 0.06 | 0.87 | 0.28 | Upgrade
|
| Levered Free Cash Flow | -21.02 | -36.92 | -19.91 | -15.51 | -5.26 | -5.6 | Upgrade
|
| Unlevered Free Cash Flow | -21.29 | -37.08 | -19.92 | -16.7 | -5.19 | -7.35 | Upgrade
|
| Change in Net Working Capital | -1.86 | 14.76 | 0.3 | 5.34 | -6.82 | -0.23 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.